Risk of developing end-stage renal disease in a cohort of mass screening

Kidney International

Volumn 49, Issue 3, 1996, Pages 800-805

  Iseki, Kunitoshi ^a   Iseki, Chiho ^a   Ikemiya, Yoshiharu ^a   Fukiyama, Koshiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DIALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; HEMATURIA; HUMAN; KIDNEY DISEASE; MASS SCREENING; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0029883141     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.111     Document Type: Article

References (34)

1. HULL AR, PARKER TF, III: Proceedings from the morbidity, mortality and prescription of dialysis symposium, Dallas, TX, September 15 to 17, 1989. Am J Kidney Dis 15:375-385, 1990
2. ISEKI K, KAWAZOE N, OSAWA A, FUKIYAMA K: Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 43:404-409, 1993
3. D'AMICO G: Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 12:353-357, 1988
4. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR, BUSICK EJ, KAHN CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985
5. ANDERSON AR, CHRISTIANSEN JS, ANDERSON JK, KREINER S, DECKERT T: Diabetic nephropathy in Type I Insulin-dependent diabetes: An epidemiological study. Diabetologia 25:496-501, 1983
6. KANNEL WB, STAMPFER MJ, CASTELLI WP, VERTER J: The prognostic significance of proteinuria. The Framingham study. Am Heart J 108:1347-1352, 1984
7. MACMAHON S: Blood pressure and the risks of cardiovascular disease, (chapt 3) in The Textbook of Hypertension, edited by SWALES JD, Cambridge, Blackwell Science, Inc., 1994, pp 46-57
8. ISEKI K, KAWAZOE N, FUKIYAMA K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
9. ISEKI K, KINJO K, KIMURA Y, OSAWA A, FUKIYAMA K: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 44:1086-1090, 1993
10. COX DR: Regression models and life tables. J R Stat Soc [B] 34:187-220, 1972
11. HARRELL F: The PHGLM, in SAS Supplemental Library User's Guide, edited by REINHARDS PS, Cary, SAS Institute Inc., 1980, pp 19-32
12. SIMON O, RAMEE MP, AUTULY V, LAURENCE E, CHARASSE C, CAM G, ANG KS: Epidemiology of primary glomerular disease in a French region. Variations according to period and age. Kidney Int 46:1192-1198, 1994
13. HUMPHREY LL, BALLARD DJ, FROHNERT PP, CHU CP, O'FALLON WM, PALUMBO PJ: Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med 111:788-796, 1989
14. ISEKI K, MIYASATO F, OURA T, UEHARA H, NISHIME K, FUKIYAMA K: An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 23:547-554, 1994
15. MOHR DN, OFFORD KP, OWEN RA, MELTON J, III: Asymptomatic microhematuria and urologic disease. A population-based study. J Am Med Assoc 256:224-229, 1986
16. WOOLHANDLER S, PELS RJ, BOR DH, HIMMELSTEIN DU, LAWRENCE RS: Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and Proteinuria. J Am Med Assoc 262:1214-1219, 1989
17. METCALF P, BAKER J, SCOTT A, WILD C, SCRAGG R, DRYSON E: Albuminuria in people at least 40 years old: Effect of obesity, hypertension, and hyperlipidemia. Clin Chem 38:1802-1808, 1992
18. REMUZZI G, BERTANI T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990
19. BONNARDEAUX A, SOMERVILLE P, KAYE M: A study on the reliability of dipstick urinalysis. Clin Nephrol 41:167-172, 1994
20. HOPPER J, JR, TREW PA, BIAVA CG: Membranous nephropathy: Its relative benignity in women. Nephron 29:18-24, 1981
21. DONADIO JV, JR, TORRES VE, VELOSA JA, WAGONER RD, HOLLEY KE, OKAMURA M, ILSTRUP DM, CHU C: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 33:708-715, 1988
22. GRETZ N, ZEIER M, GEBERTH S, STRAUCH M, RITZ E: Is gender a determinant for evolution of renal disease? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 14:178-183, 1989
23. SAKEMI T, TOYOSHIMA H, MORITO F: Testosterone eliminates the attenuating effect of castration on the progressive glomerular injury in hypercholesterolemic male Imai rats. Nephron 67:469-476, 1994
24. SACHS SH, APARICIO SAJR, BEVAN A, OLIVER DO, WILL EJ, DAVISON AM: Late renal failure due to prostatic outflow obstruction: A preventable disease. Br Med J 298:156-159, 1989
25. PERNEGER TV, WHELTON PK, KLAG MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 331:1675-1679, 1994
26. KUSUMOTO Y, TAKEBAYASHI S, TAGUCHI T, HARADA T, NAITO S: Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol 28:118-124, 1987
27. VOKONAS PK, KANNEL WB, CUPPLES LA: Epidemiology and risk of hypertension in the elderly: The Framingham study. J Hypertens 6:S3-S9, 1988
28. TELL GS, RUTAN GH, KRONMAL RA, BILD DE, POLAK JF, WONG ND, BORHANI NO, AND THE CARDIOVASCULAR HEALTH STUDY (CHS) COLLABORATIVE RESEARCH GROUP: Correlates of blood pressure on community-dwelling older adults, the Cardiovascular Health Study. Hypertension 23:59-67, 1994
29. KLAG MJ, WHELTON PK, NEATON JD, RANDALL B, FORD CE, BRANCATI FL, SHULMAN N, STAMLER J: Blood pressure and incidence of ESRD in men in the MRFIT screenee cohort. (abstract) J Am Soc Nephrol 5:334, 1994
30. WHELTON PK, KLAG MJ: Hypertension as a risk factor for renal disease: Review of clinical and epidemiological evidence. Hypertension 13:S19-S27, 1989
31. KLAHR S, LEVEY AS, BECK GJ, CAGGIULA AW, HUNSICKER L, KUSEK JW, STRIKER G, FOR THE MODIFICATION OF DIET IN RENAL DISEASE STUDY GROUP: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
32. BERGSTROM J, ALVERSTRAND A, BUCHT H, GUTIERREZ A: Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 25:1-6, 1986
33. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD, FOR THE COLLABORATIVE STUDY GROUP: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
34. DONADIO JV, JR, BERGSTRALH EJ, OFFORD KP, SPENCER DC, HOLLEY KE, MAYO NEPHROLOGY COLLABORATIVE GROUP: A controlled trial of fish oil in IgA nephropathy. N Engl J Med 331:1194-1199, 1994